SYMPOSIUM
ADCHEM is a triennial meeting of the International Federation of Automatic Control (IFAC). ADCHEM 2021 is sponsored by the IFAC Technical Committee on Chemical Process Control and co-sponsored by the IFAC Technical Committees on Non-linear Control Systems, Biosystems and Bioprocesses, and Fault Detection, Supervision and Safety of Technical Processes.
Following the traditions of the previous ADCHEM Symposia held in Toulouse (1991), Kyoto (1994), Banff (1997), Pisa (2000), Hong Kong (2003), Gramado (2006), Istanbul (2009), Singapore (2012), Whistler (2015), and Shenyang (2018), ADCHEM 2021 will bring together researchers and practitioners from all over the world, to facilitate discussions of recent developments in the control and modeling of chemical, biomedical, and other process systems.
Covering both theory and applications, the Symposium will provide an ideal opportunity for presenting new results and developments in:
MODEL-BASED CONTROL
MODELING AND IDENTIFICATION
SCHEDULING AND OPTIMIZATION
BIG DATA ANALYTICS AND MONITORING
BATCH PROCESSES
ENERGY PROCESSES
INDUSTRIAL APPLICATIONS
COPYRIGHT CONDITIONS
All publication material submitted for presentation at an IFAC-sponsored meeting (Congress, Symposium, Conference, Workshop) must be original and hence cannot be already published, nor can it be under review elsewhere. The authors take responsibility for the material that has been submitted. IFAC-sponsored conferences will abide by the highest
standard of ethical behavior in the review process as explained on the Elsevier webpage, and the authors will abide by the IFAC publication ethics guidelines.
Accepted papers that have been presented at an IFAC meeting will be published in the proceedings of the event using the open-access IFAC-PapersOnLine series hosted on ScienceDirect. To this end, the author(s) must grant exclusive publishing rights to IFAC under a Creative Commons license when they submit the final version of the paper. The copyright belongs to the authors, who have the right to share the paper in the same terms allowed by the end user license, and retain all patent, trademark and other intellectual property rights (including research data).
Revised 25 November 2019
